Current concepts in managing heart failure. Based on recent studies of beta-blocker therapy, treatment guidelines have been revised for patients who have mild, moderate, or severe HF.
Rostant
Tiffany Miller
TM
Baylor College of Medicine, Houston, Tex., USA.
Nasser
Maher
M
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D006333:Heart Failure / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D010808:Physical Examination; D011412:Propanolamines / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol